Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination Antiplatelet and Oral Anticoagulant Therapy in Patients With Coronary and Peripheral Artery Disease
Authors
Keywords
-
Journal
CIRCULATION
Volume 139, Issue 18, Pages 2170-2185
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-04-30
DOI
10.1161/circulationaha.118.033580
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)
- (2018) Warren H. Capell et al. AMERICAN HEART JOURNAL
- Noncanonical Matrix Metalloprotease 1–Protease-Activated Receptor 1 Signaling Drives Progression of AtherosclerosisHighlights
- (2018) Rajashree Rana et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Stuart J Connolly et al. LANCET
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis
- (2018) H. Spronk et al. THROMBOSIS AND HAEMOSTASIS
- D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy)
- (2018) Fahad AlKhalfan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pathology of Peripheral Artery Disease in Critical Limb Ischemia
- (2018) Navneet Narula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
- (2018) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study
- (2017) Birgitta Sigvant et al. JOURNAL OF VASCULAR SURGERY
- GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes
- (2017) Paul A Gurbel et al. LANCET
- Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
- (2017) E Magnus Ohman et al. LANCET
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
- (2017) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension
- (2017) Sabine Kossmann et al. Science Translational Medicine
- Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation?
- (2017) Bernhard Rauch et al. THROMBOSIS AND HAEMOSTASIS
- Platelet‐Derived Factor V Is a Critical Mediator of Arterial Thrombosis
- (2017) Meiping Ren et al. Journal of the American Heart Association
- 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis
- (2017) Jeffrey I. Weitz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography
- (2016) Kevin P. Bliden et al. JOURNAL OF INTERVENTIONAL CARDIOLOGY
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- (2016) Marc P. Bonaca et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The hemostatic role of factor XI
- (2016) Cristina Puy et al. THROMBOSIS RESEARCH
- Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?
- (2016) Hugo ten Cate et al. Journal of the American Heart Association
- G-Protein–Coupled Receptors Signaling Pathways in New Antiplatelet Drug DevelopmentSignificance
- (2015) Paul A. Gurbel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo
- (2015) Christian Heim et al. HEART AND VESSELS
- Tissue Factor and Atherothrombosis
- (2015) Kohei Tatsumi et al. Journal of Atherosclerosis and Thrombosis
- Effects of Rivaroxaban on Platelet Activation and Platelet–Coagulation Pathway Interaction
- (2015) Elisabeth Perzborn et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Normal Platelet Activation Profile in Patients with Peripheral Arterial Disease on Aspirin
- (2015) Johanna P. van Geffen et al. THROMBOSIS RESEARCH
- Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants
- (2014) H. M. H. Spronk et al. CARDIOVASCULAR RESEARCH
- Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome
- (2014) Jeffrey Weitz THROMBOSIS AND HAEMOSTASIS
- Vorapaxar in Patients With Peripheral Artery Disease
- (2013) Marc P. Bonaca et al. CIRCULATION
- Ticagrelor Increases Adenosine Plasma Concentration in Patients With an Acute Coronary Syndrome
- (2013) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease
- (2013) Hugo Cate et al. THROMBOSIS AND HAEMOSTASIS
- Targeting factor Xa and thrombin: impact on coagulation and beyond
- (2013) Charles T. Esmon THROMBOSIS AND HAEMOSTASIS
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- What did we learn from new oral anticoagulant treatment?
- (2012) Charles T. Esmon THROMBOSIS RESEARCH
- Accelerated In Vivo Thrombin Formation Independently Predicts the Presence and Severity of CT Angiographic Coronary Atherosclerosis
- (2012) Julian I. Borissoff et al. JACC-Cardiovascular Imaging
- RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
- (2011) Ph. Gabriel Steg et al. EUROPEAN HEART JOURNAL
- Ticagrelor Inhibits Adenosine Uptake In Vitro and Enhances Adenosine-Mediated Hyperemia Responses in a Canine Model
- (2011) J. J. J. van Giezen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
- (2011) Qianxing Zhou et al. MEDIATORS OF INFLAMMATION
- The Hemostatic System as a Modulator of Atherosclerosis
- (2011) Julian Ilcheff Borissoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
- (2011) John H. Alexander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Time dependence of clopidogrel loading effect: Platelet activation versus platelet aggregation
- (2011) Paul A. Gurbel et al. THROMBOSIS RESEARCH
- Early Atherosclerosis Exhibits an Enhanced Procoagulant State
- (2010) Julian Ilcheff Borissoff et al. CIRCULATION
- Combination Antithrombotic Therapies
- (2010) Paul A. Gurbel et al. CIRCULATION
- Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: Results of the Thrombotic RIsk Progression (TRIP) Study
- (2010) Udaya S. Tantry et al. PLATELETS
- Inhibition of Coagulation Activation and Inflammation by a Novel Factor Xa Inhibitor Synthesized from the Earthworm Eisenia andrei
- (2009) Seong Soo Joo et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
- (2009) JL Mega et al. LANCET
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic blood coagulation activation in acute coronary syndromes
- (2008) A. Undas et al. BLOOD
- The active metabolite of prasugrel effectively blocks the platelet P2Y12receptor and inhibits procoagulant and pro-inflammatory platelet responses
- (2008) Heather M. Judge et al. PLATELETS
- Factor Xa: at the crossroads between coagulation and signaling in physiology and disease
- (2008) Keren Borensztajn et al. TRENDS IN MOLECULAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started